His-Purkinje-related ventricular arrhythmias are a subset of ventricular tachycardias that use the specialized cardiac conduction system. These arrhythmias can occur in various different forms of structural heart disease. Here, we review the basic science discoveries and their analogous clinical observations that implicate the His-Purkinje system as a crucial component of the arrhythmia circuit. While mutations serve the molecular basis for arrhythmias in the heritable cardiomyopathies, transcriptional and posttranslational changes constitute the adverse remodeling leading to arrhythmias in acquired structural heart disease. Additional studies on the electrical properties of the His-Purkinje network and its interactions with the surrounding myocardium will improve the clinical diagnosis and treatment of these arrhythmias.
INTRODUCTION
Perturbation of the His-Purkinje system can lead to life-threatening ventricular arrhythmias, including ventricular tachycardia (VT) or ventricular fibrillation (VF). These arrhythmias can be idiopathic, as reviewed recently, 1 or they can occur in the context of structural heart disease. This review will highlight the molecular understanding and clinical features of His-Purkinje-related arrhythmias in the structurally abnormal heart.
PURKINJE FIBER REMODELING IN STRUCTURAL HEART DISEASE AND HEART FAILURE
Numerous ion channels and their functions are altered in cardiac cells from the failing human/animal heart. The well-described increase in action potential duration (APD) in heart failure (HF) ventricular myocytes as well as in Purkinje cells (PCs) could easily underlie early afterdepolarization (EAD)-dependent focal activations ( Figure 1 ). 2 This loss of repolarization reserve is secondary to decreases in both cardiac K + (I K ) and L-type Ca 2+ currents (I Ca,L ). 3 Changes in these currents reset the action potential (AP) plateau voltages. Slow conduction observed in mapping studies may exist due to loss-of-function in the cardiac Na + current (SCN5A), where density of the cardiac Na + channels is decreased and Na + channel inactivation is defective, also leading to the prolonged APD. Additionally, downregulation and intense phosphorylation of connexin 43 (Cx43) proteins lead to decreased function in HF cell pairs to alter cell-to-cell conduction. 4 Enhanced Purkinje focal activations in the failing heart could also be due to changes in channel expression of the I f current (the so-called pacemaker current). Most studies have been completed by providing evidence of I f expression and its enhancement in ventricular cells of HF hearts. 5 Concomitant with enhanced I f expression, there is a reduced expression of the inward rectifying K + current (I K1 ) channel and elevated -adrenergic stimulation in HF myocytes. While remodeled PCs isolated from failing hearts have been studied, 6 I f current changes were not mentioned.
However, just as important to the substrate for initiation of arrhythmias, are the marked changes in intracellular Ca 2+ handling, which can enhance the development of delayed afterdepolarizations (DADs) 7 
in
PCs from HF hearts. DADs are relatively easily induced in hypertrophied ventricular cells 8 and failing ventricular trabeculae. 9, 10 In some cases, a role for transient inward current (I TI ) and Ca i has been implicated. Traveling Ca 2+ waves have been illustrated in isoproterenol stimulated cells 11 and trabeculae from the failing rat heart. 10 Evidence provided by epicardial and endocardial mapping of ex vivo failing human hearts suggests that VTs arise in a substrate exhibiting slowed conduction. Premature stimulation produces progressive conduction delay and the first beat initiating VT is from the subendocardium. 12, 13 Mapping studies in the rabbit model of HF revealed a similar location of initiating impulses consistent with nonreentrant, focal activations from Purkinje laden myocardium.
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c 2018 Wiley Periodicals, Inc. 1051 wileyonlinelibrary.com/journal/pace F I G U R E 1 Single ventricular cell action potential recordings from different areas of failing hearts in control conditions, from a failing heart with DHF, and from a heart after CRT. Note changes in rate induced APD shortening. Adapted from Aiba and Tomaselli. 2 APD = action potential; CRT = cardiac resynchronization therapy; DHF = left ventricular dyssynchrony
Purkinje fiber remodeling post-myocardial infarction
From the endocardial mapping studies of the ex vivo healed infarcted human heart, a majority of VT episodes have been observed where endocardial activation preceded epicardial activation. It seemed that a majority of VTs were due to reentrant activity. Some studies showed that initial focal activations spread from small areas to the remaining tissues. 14 These authors concluded that endocardial APs were relatively normal and that the recorded fragmented extracellular electrograms were due to complex anatomical heterogeneities, such as the observed increased fibrosis. Sustained monomorphic VTs postmyocardial infarction (MI) in the human heart appeared to be due to focal activation that arose in the subendocardium or intramural reentry from the subendocardium as well as epi-and midmyocardium. 14 In hearts of large animals, acute coronary artery occlusion results in rapid ventricular arrhythmias (VT or VF), as reviewed previously. 15 It is unlikely that chronic or persistent changes in ion channel function in cells of substrate underlie these acute arrhythmias. Over the following 24-48 h during the subacute phase postocclusion, delayed spontaneous ventricular arrhythmias originating from the subendocardial Purkinje fibers occur in both experimental models and humans. During the healing phase (days, weeks) or healed (months) infarct phase, sustained VTs are inducible with programmed stimulation, suggesting that a reentrant substrate is present. The sites of origin of the ventricular arrhythmias in these hearts depend on the location of the surviving cells overlying the infarcted region.
Mechanisms for some of these ventricular arrhythmias can be understood in terms of the alterations in cellular electrical activity (remodeling) in specific regions of the heart post-MI. Generally, by 24-48 h after total coronary artery occlusion, the APs of the subendocardial border zone Purkinje fibers show reduced resting potentials and maximal AP upstroke velocity (Vṁax), as well as an increase in the total time of repolarization (Figure 2 ). 16 It is likely that there is a net decrease in potassium permeability of the sarcolemma in PCs with reduced resting potentials. This is consistent with a decrease in the density of both the transient outward K + current (I to ) and I K1 . 17, 18 By virtue of the loss in resting potential, there would be a predictable change in Vṁax of the subendocardial Purkinje myocytes that survive in the infarcted myocardium. While the Na + channel protein/function
is not yet altered, the expression of its adapter protein Ankyrin-G is still robust and increases. 19 Gap junctional proteins (Cx40 and Cx43) are altered in assembly but have not yet redistributed along the sarcolemma by 48 h postocclusion in PCs.
Importantly, peak L-type Ca 2+ current density is significantly reduced in subendocardial Purkinje myocytes dispersed from the 48-h infarcted heart. 20 The loss in Ca 2+ channel function could contribute to the depressed and triangular plateau phase of the prolonged APs of these arrhythmogenic Purkinje myocytes (Figure 2 ). 16 Despite reduced Ca 2+ currents, PCs post-MI show an increase in travelling Ca 2+ waves, which by activating the sodium-calcium exchanger (NCX), cause DADs and triggered activity. 21 Purkinje fibers also show variable degrees of automaticity as well as exit block (Figure 3 ). Slowed and inhomogeneous conduction, particularly at rapid rates, within the subendocardial Purkinje fibers of this substrate may be due to marked changes in Cx43 location and function in pairs as is found in the 5-day epicardial border zone surviving cells. [22] [23] [24] However, segments of the intercalated Purkinje to Purkinje discs appear no different from those of normal subendocardium. 25 About 2 months postcoronary artery occlusion, the process of ion channel reverse remodeling of the cardiac cell is ongoing. The APs of the subendocardial PCs that were arrhythmogenic 24-48 h postocclusion period have improved considerably. Resting potentials, Vṁax, and action potential amplitude have returned to near control levels. The time course of APD changes is illustrated in Figure 2 . 16, 26 The most significant change that occurs in the post-MI healed animal heart is the replacement of ventricular myocytes with fibrosis tissue. Thus, the subendocardial layers of PCs that survive are anatomically "isolated" becoming a 2D sheet.
Purkinje fibers in heritable cardiomyopathies
Several groups have described the genetic basis of an inherited but rare arrhythmogenic disorder, catecholamine polymorphic ventricular F I G U R E 3 Two examples of PF activity recorded from subendocardium of the post-myocardial infarction heart. A, Shows a PF AP that is spontaneously active with a slow phase 4 of depolarization. It is not stimulated. Lower is AP from a PF in an adjacent region that is activated by the spontaneous PF above. B, Shows APs from three sites in another infarcted preparation. In one and two, stimulus activates healthy-looking APs. In three, a PF AP that is spontaneously active appears not to be affected by the stimulation. When stimulus is turned off, PF of three continues to depolarize but does not activate the other regions (exit block). Adapted from Janse and Wilt. 15 AP = action potential; PF = Purkinje fiber tachycardia (CPVT), as an autosomal dominant mutation in the cardiac ryanodine receptor (RYR2) 27, 28 or homozygous and heterozygous missense mutations in the calsequestrin 2 (CASQ2) gene. 29 These genes control levels of proteins critical for proper Ca 2+ handling in Purkinje myocytes. While a mutation in a stated gene will affect functions in all cardiomyocytes, cardiac PCs from one mouse model of CPVT (RyR2 R4496C) showed enhanced sensitivity to the Ca 2+ dysregulation caused by the gain of function of the mutated RyR2 protein, so called Ca 2+ leak. 27, 30, 31 Thus triggered focal activations preceding any VTs/VF in these hearts are highly likely to be Purkinje related.
However, PCs can be sources of other ventricular arrhythmias (e.g., short-coupled torsades de pointes) in hearts that exhibit lossin-function mutations in RyR2 protein. [32] [33] [34] This loss in function occurs because the mutated RyR2 protein is hypoactive and does not release large amounts of Ca 2+ from the sarcoplasmic reticulum due to decreased and changed inactivation time course of the L-type Ca 2+ current. This could prolong luminal Ca 2+ activation. The resultant prolonged Ca 2+ release is hypothesized to lead to EADs and potentially a premature ventricular contraction (PVC) at a short coupling interval. 33 Others have described probands with similar electrocardiograms (ECG) that were found to have gain-of-function mutations of KCNE5 (encoding for MiRP 4 subunit), a regulatory subunit, on the function of the cell's voltage-dependent transient outward current (I to1 ). 35 Adult PCs have a large I to1 and thus a considerable "notch" in the AP. 17 Subsequently, mutations in two other regulatory proteins, dipeptidyl peptidase like 6 (DPP6) and DPP6-T, affect the magnitude of I to1 in PCs resulting in an arrhythmogenic substrate. 36,37
Long and short QT intervals
Genetically-based long QT (LQTS) or short QT (SQTS) syndromes can occur with mutations in several K + and Na + channels and clearly would affect both PCs and myocytes. However, as shown in a study using LQTS Type 3 mice (delta KPQ), 38 the PC repolarization phase is more sensitive to these mutations than that of ventricular cells and are probable sources of EAD-or DAD-induced arrhythmias.
Shortened QT intervals and poor rate adaptation are hallmarks of SQTS. Gain-of-function mutations in K + channels (e.g., KCNH2, encoded by hERG, I Kr ), as well as RYR2 gene (see above) have been identified in patients. In the first example, the SQTS hERG mutation has a dramatic effect on Purkinje AP when studied under AP voltage-clamp conditions. 39 The amount of mutated I Kr is increased in the PC as well as in ventricular cells, thus significantly altering AP repolarization.
Additionally, the mutated hERG channel augments the current associated with early premature stimuli, thus increasing the vulnerability to PVCs.
Conduction slowing/block
Heritable conduction slowing and/or block in His-Purkinje system can be caused by ion channel mutations that change the Purkinje AP and/or the coupling between PCs. Well-known are the loss-of-function mutations in the ∝ subunit of the sodium channel Na V 1.5, encoded by SCN5A. These can lead to forms of conduction disease and/or hyperexcitable Purkinje fiber bundles. For example, there is a SCN5A mutation with net gain of function of the Na + channel, particularly in the −80 to −40 mV range. A new syndrome, multiple ectopic Purkinjerelated premature depolarizations, has been defined. 40 Electrophysiological (EP) studies revealed that all premature beats originated from Purkinje tissues. A similar gain-of-function SCN5A mutation (a shift in the "window" current) was found associated with a large kindred with dilated cardiomyopathy (DCM) and PVCs. 41 In these individuals, a history of palpitations preceded the DCM diagnosis suggesting that the DCM may have resulted from the Purkinje ectopy and enhanced Na + influx.
Important modifiers of the cardiac sodium channel, the 1 subunits, can themselves be mutated and decrease Na V 1.5 function and lead to conduction slowing/bundle branch block in the absence of SCN5A mutations. 42 However, these EP changes rarely end in VT. Recently, idiopathic bundle branch reentrant VT has been described in some patients where mutations in either SCN5A or LMNA (for lamin A and C proteins) have been described. 43 In this case, SCN5A mutations would be consistent with loss-of-function of the Na + channel leading to a decrease in peak I Na and reduced "window current" late I Na . Lamins are important for the integrity of the nuclear membrane. Their dysfunction often leads to DCM and conduction disease.
Arrhythmias involving the Purkinje system in patients with ischemic cardiac disease
The role of the Purkinje system in the geneses of ventricular arrhythmias in animal models of ischemic heart disease has been discussed above. This section will focus on the clinical counterpoints of these observations as they relate to either acute ischemia or healed MI.
The role of the Purkinje system for triggering VF in patients with structurally normal hearts was first described by Haïssaguerre et al. 44 F I G U R E 4 Intracardiac electrogram during triggering PVC. Mapping catheter is at the successful ablation site. No diastolic potential detected after first two atrial paced beats (arrow). Note Purkinje potential preceding PVC after third atrial paced beat by 97 ms. Adapted from Bänsch et al. 45 PVC = premature ventricular contraction They discovered that triggered PVCs emanating from Purkinje tissue could cause VF and that these patients could be cured by ablation of these triggers. This observation was first extended to patients with recent MI with recurrent episodes of VF by Bänsch et al. 45 These authors described four patients with electrical storm following an acute MI, which proved refractory to drug therapy (including intravenous amiodarone and -blockers) or acute revascularization, and were found to have PVCs that served to trigger VF or polymorphous VT. In each patient, a Purkinje potential preceded the QRS in sinus rhythm and was present before the triggering PVC. This potential preceded the QRS during VT prior to development of VF (Figure 4) . In each patient, the trigger PVC had a right bundle branch block (RBBB) with superior or inferior axis compatible with a fascicular origin. Of note, the Purkinje to QRS interval during sinus rhythm was 23-25 ms in front of the QRS and preceded the QRS during VT by 126-160 ms.
These potentials were always found at the anatomic border zone of the infarct (similar to that found in animal models of acute ischemia).
They found that multiple applications of radiofrequency energy (6-50 Hz) were necessary to abolish the local Purkinje potentials (as well as the trigger PVCs) suggesting involvement of a broad area of diseased fibers. This procedure proved effective in abolishing VT or VF in all treated patients and provides clinicians with an important tool for management of critically ill patients.
The role of the Purkinje system for patients with healed MI
Marrouche et al. 46 were the first to systematically describe the role of the Purkinje system in eight patients with electrical storm, which occurred approximately 11 months after an acute MI. These patients proved refractory to medical management and underwent detailed EP studies as well as electroanatomic mapping. In each, a Purkinje potential was recorded, both during sinus rhythm as well as during the trigger PVC from the anatomic border zone, as determined from the 3D map.
In five patients, PVC mapping was possible because of high-density PVCs while in three patients, Purkinje like potentials were empirically ablated in the infarct border zone. After ablation, there was no recurrence of VT storm, but one patient had recurrence of a single episode of VF while another had sustained monomorphic VT, which was successfully ablated. These observations highlight the role of the Purkinje system for those with well-healed MI. These observations together with those described in the Bänsch study suggest that the Purkinje system acts as a trigger for either triggered rhythms or possibly microreentrant rhythms involving the Purkinje system.
On the other hand, Bogun et al. 47 described the importance of the Purkinje system for those with macroreentrant VT circuits in patients with healed MI. They described nine patients with sustained monomorphic VT and a QRS duration < 145 ms, and who were studied a mean of 4.7 years after MI. Most (eight of nine) suffered an inferior MI while one had an anteroseptal MI. Most showed a RBBB with superior axis.
All underwent anatomic as well as entrainment mapping. They used the following criteria to prove that the Purkinje system was part of the circuit: (1) Others have also described involvement of the Purkinje system post-MI. [48] [49] [50] In most, the mechanism was related to bundle-to-bundle reentry or fascicular reentry, which are discussed next. Other reports likewise describe fascicular tachycardia either due to reentry 50 or abnormal automaticity. 49 
His-Purkinje-derived VTs
Both macroreentry and focal VTs involving the His-Purkinje system have been implicated in structural heart disease. His-Purkinje-related VTs were found in 20 of 234 patients with VT in a single-center, retrospective series. 49 The majority of these patients (55%) had ischemic cardiomyopathy, and 60% of these patients also had inducible scarrelated VT. Three varieties of His-Purkinje-related VTs were identified including bundle branch reentry, which was by far the most common, and the less frequent types of interfascicular reentry and focal fascicular tachycardia. While all the His-Purkinje-related VTs were amenable to catheter ablation, there was high-grade atrioventricular block in 30% of the patients, and treatment required concomitant antiarrhythmic therapy and/or implantable defibrillator. Figure 7B ). These findings were initially described in an early clinical series that detailed 20 consecutive patients with sustained bundle branch reentry from a single center. 51 The authors found that 95% (19 of 20 patients) had DCM and more than half (11 of 20 patients) had a predominant nonischemic etiology and left ventricular dysfunction; one patient had an aortic valve prosthesis for severe aortic regurgitation. These patients were combined into a later published series 52 to include a total of 48 patients with inducible bundle branch reentry tachycardia, again the vast majority of which were LBBB morphology. Interestingly, two induced tachycardias had an interfascicular mechanism, described in more detail below.
Like all macroreentry circuits, bundle branch reentry relies on relative conduction delays, in this case, within a diseased His-Purkinje system and diseased transseptal myocardial conduction tissue. Therefore, bundle branch reentry tachycardias typically occur in the setting of cardiomyopathy because a normal conduction system cannot sustain this type of tachyarrhythmia. Likewise, complete bundle branch block would also not allow reentry to occur, which serves the basis for catheter ablative therapy of the right bundle [51] [52] [53] or the left bundle. 54 The latter study described electroanatomic mapping in four patients with bundle branch reentry tachycardia and LBBB morphology. In all four patients, there was no conduction in the anterior fascicle and slow conduction in the posterior fascicle. Left ventricular activation in two of the four patients was via slow conduction through the left posterior Purkinje fibers and via passive transseptal propagation in the other two patients. The authors speculated that the absence of conduction in the anterior fascicle is secondary to its susceptibility to ischemic injury. More recent, recognition of bundle branch reentry tachycardia in structurally normal hearts 43 suggests that genetic mutations may result in conduction delay, which serves as a substrate for bundle branch reentry.
Interfascicular and intrafascicular tachycardia in structural heart disease
One of the first case reports on successful ablation for interfascicular reentry tachycardia was described in a patient who previously had The aforementioned slow conduction properties of the left posterior fascicle allow for reentry between the branches of the fascicle, described in four patients post-MI. 50 While the left anterior fascicle is anatomically vulnerable to ischemic injury, the posterior fascicle, being anatomically broader, seems resistant. 57 The conduction system appeared preserved in the majority (three out of four) of these patients as evidenced by normal HV interval. During tachycardia, changes in the Purkinje to Purkinje potential intervals, as opposed to 
Focal tachycardia
Focal tachycardia involving the His-Purkinje system is rare. In a series of 234 patients with recurrent VT in context of heart disease, there were only two patients found with focal tachycardia from the specialized conduction system, one in the left bundle branch and one in the right. 49 The electrophysiologic features are similar to propranololsensitive autonomic VT. 58 These tachycardias were induced by isoproterenol and not induced by programmed extrastimulation. They show transient response to adenosine but are not responsive to verapamil. Ablation targeted the interventricular septum at a site where there was the earliest Purkinje potential, and this induced a flurry of ectopic beats and was successful at terminating the tachycardia. These tachycardias are not always responsive to ablation. In a retrospective study of eight patients with fascicular arrhythmia of various etiologies, catheter ablation was successful in two out of five attempted cases; the other three patients responded to either verapamil or encainide. 59 The majority of these patients had preserved left ventricular systolic function, and of the three patients who had a cardiomyopathy, two patients did not undergo EP study, and one patient had multiple fascicular arrhythmias and failed ablation.
Distinguishing tachycardia mechanism
The differentiation of tachycardia mechanism is challenging. We currently use a technique that a number of recent authors have proposed, 60 namely retrograde aortic insertion of a multipolar electrode catheter along the posterior or anterior fascicle, whichever is thought to be the culprit. Another catheter is then introduced via a transseptal route for mapping and ablation. For nonreentrant or focal fascicular VT, the putative fascicle involved is identified in sinus rhythm as showing an anterograde activation pattern. Entrainment is not possible when pacing from then right ventricular (RV) apex or from the atrium. Nogami and colleagues found that during VT a retrograde fascicular activation pattern was discerned and the site of successful ablation was at the longest fascicle to V interval. 60 For those with reentrant fascicular VT, a two catheter technique is employed as described above, and we employ entrainment pacing from the RV apex to prove a reentrant mechanism. If the patient is stable during tachycardia, the left ventricle is mapped using a 3D imaging system to best delineate the tachycardia circuit. For the more common reentrant fascicular tachycardia, the ablation is carried out over the diastolic potentials or P1 area if this can be identified. Otherwise, we use the earliest fascicle to V or the insertion site of P1 into P2.
It is important to distinguish a fascicular potential from isolated muscle potential. The key is to position the catheter over the fascicle in question and record the anterograde activation pattern in sinus rhythm. Once this is defined, we see whether these potentials precede the QRS during tachycardia. For the nonreentrant fascicular tachycardia, the earliest fascicular potential to QRS has been reported at 25 ± 16 ms. 60 Finally, arrhythmias arising from the papillary muscles are important potential confounders because the fascicles are anchored to these muscles. The surface ECG is key. Papillary muscle VT is broader than fascicular VT and will show a qR rather than a rR' pattern in V1. Intracardiac echocardiography is always used in order to best define the boundaries of the papillary muscles during ablation. Fascicular potentials may be recorded either just before or within the QRS.
CONCLUSIONS
His-Purkinje-related arrhythmias can occur in various different forms of structural heart disease. The site of injury to the conduction system translates into molecular changes at that location and gives rise to substrate for arrhythmia. There are common cellular mechanisms underlying these arrhythmias, including slow conduction allowing for reentry, triggered activity, and enhanced automaticity. Our understanding and treatment approach for these arrhythmias will continue to evolve with advances in both cellular and clinical EP studies.
